Press Releases July 30, 2026 06:50 AM

ScottsMiracle-Gro Announces Speakers and Other Details for its Investor Day on August 4, 2026

ScottsMiracle-Gro to Present Multi-Year Growth Strategy and Financial Targets at Upcoming Investor Day

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
SMG

ScottsMiracle-Gro announced details for its August 4, 2026 Investor Day at the New York Stock Exchange, featuring its executive leadership team outlining the SMG 2.0 growth strategy focusing on portfolio optimization, channel expansion, category growth, and operational efficiencies. The company will also discuss its disciplined capital allocation approach and longer-term financial targets aimed at dependable net sales growth and profitability expansion.

ScottsMiracle-Gro Announces Speakers and Other Details for its Investor Day on August 4, 2026
SMG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive leadership will present a multi-year growth strategy emphasizing portfolio optimization and operational efficiencies.
  • The company plans to discuss capital allocation including leverage reduction, investments, and acquisitions.
  • Financial targets include dependable net sales growth and consistent profitability expansion.
  • Sectors impacted include consumer goods, specifically lawn and garden product markets, retail channels, and capital markets.

MARYSVILLE, Ohio, July 30, 2026 (GLOBE NEWSWIRE) --

The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced details for its Investor Day on Tuesday, August 4, 2026, at the New York Stock Exchange. Investors and media can view the event via live stream.

The speakers, each of whom will provide formal presentations followed by a Q&A session, include:

  • Nate Baxter, president and CEO
  • Mark Scheiwer, EVP, chief financial officer and chief accounting officer
  • Nick Miaritis, EVP, chief brand officer
  • John Sass, SVP & general manager, North America
  • Josh Meihls, SVP, chief growth officer
  • Dr. Paula Powell, SVP, research & development
  • David Huskisson, SVP, operations & technology
  • Sadie Oldham, VP & general manager, Gardens

Among the themes and topics to be addressed:

  • SMG 2.0 growth strategy: Multi-year, in-depth look at portfolio optimization, channel expansion, category growth and operational efficiencies.
  • Disciplined capital allocation: Strategic approach to balance sheet management, including leverage reduction, SG&A investments, capital expenditures, tuck-in M&A and shareholder friendly actions.
  • Longer-term growth algorithm: Plans for dependable net sales growth and consistent profitability expansion, including key financial targets.

Investor Day will be held at the New York Stock Exchange on August 4, 2026, beginning at 9 a.m. ET. For those interested in viewing online, the live webcast can be accessed through Vimeo. For those unable to participate during the live webcast, a replay will be available on the Investor Relations website.

About ScottsMiracle-Gro
With approximately $3.3 billion in sales, the Company is the leading marketer of branded consumer lawn and garden products in North America. The Company’s brands are among the most recognized in the industry. The Company’s Scotts®, Miracle-Gro®, Ortho® and Tomcat® brands are market-leading in their categories. For additional information, visit us at www.scottsmiraclegro.com

For investor inquiries:
Brad Chelton
Vice President
Treasury, Tax and Investor Relations
[email protected]
(937) 309-2503

For media inquiries:
Tom Matthews
Chief Communications Officer
[email protected]
(937) 844-3864


Risks

  • Execution risk in delivering multi-year growth targets and operational improvements.
  • Potential challenges in capital allocation balancing leverage reduction with investments and acquisitions.
  • Market risks affecting consumer demand for lawn and garden products.

More from Press Releases

Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026 Jul 30, 2026 Innventure to Announce Second Quarter 2026 Results on August 13, 2026 Jul 30, 2026 Stantec joint venture selected by U.S. Army Corps of Engineers to advance coastal resilience on Charleston’s peninsula Jul 30, 2026 Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights Jul 30, 2026 Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing Jul 30, 2026